|
Athos Therapeutics Inc.
Los Angeles, USA
|
|
Athos Therapeutics Inc. is a clinical-stage biotechnology company developing AI- and machine-learning-driven precision small-molecule therapies for autoimmune and chronic inflammatory diseases, particularly inflammatory bowel disease (IBD). The company combines multi-omics patient data, systems biology, computational chemistry, and machine learning to identify novel drug targets and design potential therapies. Its lead candidate, ATH-063, is an oral small molecule being developed for ulcerative...